Safety of Remdesivir for Patients 80 Years of Age or Older with Coronavirus Disease 2019 (COVID-19).

Osamu KanaiKohei FujitaKazutaka NanbaNaoki EsakaHiroaki HataKoichi SetaAkihiro YasodaTakao OdagakiTadashi Mio

Published in: Drugs & aging (2021)

The safety of remdesivir was suggested to be comparable between patients older than 80 years of age and patients younger than 80 years of age. The results of this study may encourage the administration of remdesivir to this older patient group.

Keyphrases

coronavirus disease
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
physical activity
middle aged
community dwelling
patient reported